
| Source: | Rabbit | Gene Id: | 3620 | 
| Isotype: | IgG | Swiss Prot: | P14902 | 
| purity: | Affinity purification | 
| Background: | 
| INDO/IDO1/indoleamine 2,3-dioxygenase (IDO) is an IFN-γ-inducible enzyme that catalyzes the rate-limiting step of tryptophan degradation (1). IDO is upregulated in many tumors and in dendritic cells in tumor-draining lymph nodes. Elevated tryptophan catabolism in these cells leads to tryptophan starvation of T cells, limiting T cell proliferation and activation (2). Therefore, IDO is considered an immunosuppresive molecule, and research studies have shown that upregulation of IDO is a mechanism of cancer immune evasion (3). The gastrointestinal stromal tumor drug, imatinib, was found to act, in part, by reducing IDO expression, resulting in increased CD8+ T cell activation and induction of apoptosis in regulatory T cells (4). In addition to its enzymatic activity, IDO was recently shown to have signaling capability through an immunoreceptor tyrosine-based inhibitory motif (ITIM) that is phosphorylated by Fyn in response to TGF-β. This leads to recruitment of SHP-1 and activatation of the noncanonical NF-κB pathway (5). | 
| Reactivity | Human | 
| Tested applications | WB IHC | 
| Clonality | Polyclonal Antibody | 
| Calculated MW | 45 kDa | 
| Recommended Dilutions | 
                                     WB 1:500-1:2000 
                                    IHC 1:50-1:200 
                                    
                                    
                                    
                                    
                                    
                                 | 
                            
| Immunogen | A recombinant protein of human INDO | 
| Storage | Store at -20°C or -80°C in PBS with 0.02% sodium azide and 50% glycerol. Avoid freeze/thaw cycles. | 
| Synonym | CD107B, IDO, INDO | 
沪ICP备15003525号-1 Copyright ©, 2013-2022, Yihyson All Rights Reserved.